Austin, May 02, 2025 (GLOBE NEWSWIRE) -- Pediatric Interventional Cardiology Market Size & Growth Analysis:
According to SNS Insider, the Pediatric Interventional Cardiology Market was valued at USD 2.28 billion in 2023 and is projected to reach USD 5.19 billion by 2032, growing at a CAGR of 9.58% over the forecast period from 2024 to 2032.
The Pediatric Interventional Cardiology Market is experiencing sustained growth due to increasing cases of congenital heart defects, development in catheter-based procedures technology, and high demand for minimally invasive treatments. Favorable government policies, improved awareness, and enhanced pediatric health infrastructure promote market growth. With an emphasis on early detection and innovation, the market will continue to expand, especially in emerging economies where pediatric patient pools are rising.
Get a Sample Report of Pediatric Interventional Cardiology Market@ https://www.snsinsider.com/sample-request/6082
The U.S. Pediatric Interventional Cardiology Market was estimated at USD 0.69 billion in 2023 and is expected to reach USD 1.46 billion by 2032, at a CAGR of 8.77% during the forecast period of 2024-2032. The U.S. led the North American Pediatric Interventional Cardiology Market in 2023 due to strong healthcare infrastructure, high volume of procedures, and early adoption of new pediatric cardiac devices. The presence of major players and established pediatric cardiac centers strengthens its leading status.
Key Pediatric Interventional Cardiology Companies Profiled in the Report
- NuMed Inc.: Z-6 Balloon Catheter, Tyshak II Balloon Catheter
- Medtronic: Harmony Transcatheter Pulmonary Valve System, Melody Transcatheter Pulmonary Valve
- GE Healthcare: Vivid Cardiovascular Ultrasound Systems, LOGIQ E10 Ultrasound
- Gore Medical: CARDIOFORM Septal Occluder, HELEX Septal Occluder
- Abbott: Amplatzer Septal Occluder, Amplatzer Piccolo Occluder
- Cordis: PALMAZ Blue Balloon-Expandable Stent, Sleek OTW Catheter
- Edwards Lifesciences: SAPIEN XT Transcatheter Heart Valve, SAPIEN 3 Ultra System
- Siemens Healthineers: ACUSON SC2000 Ultrasound System, ARTIS icono angiography systems
- Toshiba Medical Systems (Canon Medical Systems): Aplio i-series Ultrasound, Alphenix Interventional Systems
- Biotronik: Orsiro Mission Drug-Eluting Stent, Passeo-18 Lux Drug-Coated Balloon
- Terumo Corporation: Misago Peripheral Self-Expanding Stent, Glidewire GT Guidewire
- Boston Scientific Corporation: ACURATE neo Aortic Valve System, Ranger Drug-Coated Balloon
- Cardinal Health: Cordis ADROIT Guiding Catheter, Cordis EMPIRA Pre-dilatation Balloon
- B. Braun SE: SeQuent Please NEO Drug-Eluting Balloon, Coroflex ISAR NEO Stent
- MicroPort Scientific Corporation: Firehawk Rapamycin Target Eluting Stent, VitaFlow Transcatheter Aortic Valve
Pediatric Interventional Cardiology Market Report Scope
| Report Attributes | Details |
| Market Size in 2023 | US$ 2.28 billion |
| Market Size by 2032 | US$ 5.19 billion |
| CAGR | CAGR of 9.58% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Key Regional Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East]), Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia Rest of Latin America) |
Segment Analysis
By Device Type, Transcatheter Heart Valves Segment Dominates the Market, Closure Devices to Register Fastest Growth
The transcatheter heart valves segment dominated the pediatric interventional cardiology market with a 35.2% market share in 2023 because of its major contribution to the treatment of complex congenital heart diseases through minimally invasive interventions. These valves provide essential solutions for pediatric patients who are not good candidates for open-heart surgery. Their capacity to minimize hospital stays, decrease procedural risks, and facilitate faster recovery times has made them a popular option among pediatric cardiologists. In addition, advances in technology and better device designs optimized for smaller body structures have broadened their use in children. Good clinical results, combined with more regulatory clearances and rising experience of interventional cardiologists, also helped them achieve market leadership in 2023.
The Closure Devices segment will show the fastest growth rate in the pediatric interventional cardiology market throughout the forecast period. The expansion is fueled primarily by the increase in the prevalence of atrial septal defects (ASDs), ventricular septal defects (VSDs), and patent ductus arteriosus (PDA) in children. Closure devices provide a minimally invasive, highly effective technique for treating such conditions, particularly in younger patient groups. Developments in the miniaturization of devices and more advanced delivery systems have improved safety and efficacy for pediatric use.
By Procedure, Congenital Heart Defect Correction Procedures Segment Dominates the Market
The congenital heart defect correction Procedures segment led the pediatric interventional cardiology market with a 41.7% market share in 2023 because of the high incidence of congenital heart anomalies among infants and newborns worldwide. These procedures, such as septal defect closure and valve repair, are vital to enhancing survival rates and improving the quality of life in children. The trend towards minimally invasive methods has improved procedural results and shortened recovery periods, increasing the acceptability of such interventions. Raised awareness, better diagnosis at an early stage with prenatal and neonatal screening, and improvement in interventional instruments further added to the dominance of this segment during 2023.
By End User, the Hospitals Segment Dominates the Market
The Hospitals segment led the pediatric interventional cardiology market with a 68.9% market share in 2023 because of the presence of sophisticated medical infrastructure, pediatric cardiology units with specialized facilities, and experienced interventional cardiologists. Hospitals are usually the first point of treatment for complicated congenital heart disease and provide holistic services such as diagnosis, treatment, and monitoring after the procedure. Their possession of state-of-the-art imaging equipment, catheterization labs, and emergency services also reinforces their leading status. Also, positive reimbursement policies, government assistance for pediatric care, and the availability of multidisciplinary teams are factors that contribute to the increasing trend towards hospitals handling pediatric interventional cardiology procedures.
Pediatric Interventional Cardiology Market Segmentation
By Device Type
- Transcatheter Heart Valves
- Closure Devices
- Catheters
- Guidewires
- Balloons
- Stents
- Others
By Procedure
- Angioplasty
- Coronary Thrombectomy
- Congenital Heart Defect Correction
- Catheter-based Valve Implantation
- Others
By End User
- Hospitals
- Ambulatory Surgical Centers
- Others
Need Any Customization Research on Pediatric Interventional Cardiology Market, Enquire Now@ https://www.snsinsider.com/enquiry/6082
Regional Insights
North America Dominates the Pediatric Interventional Cardiology Market, Asia-Pacific Expected to Register Fastest Growth
North America dominated the pediatric interventional cardiology market with a 38.5% market share in 2023, with its established healthcare infrastructure, increased usage of state-of-the-art interventional treatments, and widespread presence of prominent medical device manufacturers. The support of favorable reimbursement policies, increased awareness among healthcare professionals and parents, and extensive research and development activities also contribute to dominance in the market. The region also enjoys a strong network of pediatric cardiologists and specialized centers for better diagnosis and treatment of congenital heart defects in infants and children.
Asia-Pacific is expected to experience the fastest growth in the pediatric interventional cardiology market over the forecast period. The growth is being driven by a growing pediatric population, rising cases of congenital heart diseases, and enhanced access to quality care. Government investments in healthcare infrastructure, rising awareness regarding early intervention in cardiac care, and growing medical tourism opportunities in countries such as India and China are driving market growth.
Buy a Single-User PDF of Pediatric Interventional Cardiology Market Analysis & Outlook Report 2024-2032@ https://www.snsinsider.com/checkout/6082
Table of Contents – Major Key Points
1. Introduction
2. Executive Summary
3. Research Methodology
4. Market Dynamics Impact Analysis
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence of Congenital Heart Defects (CHD) in Pediatric Population (2023), by Region
5.2 Prescription Trends for Pediatric Cardiology Drugs (2023), by Region
5.3 Device Adoption Trends in Pediatric Interventional Cardiology (2020-2032), by Region
5.4 Healthcare Spending on Pediatric Interventional Cardiology, by Region (Government, Commercial, Private, Out-of-Pocket), 2023
5.5 Pediatric Interventional Cardiology Hospital Admissions and Patient Demographics (2023)
5.6 Research and Development Trends in Pediatric Interventional Cardiology (2020-2032)
6. Competitive Landscape
7. Pediatric Interventional Cardiology Market by Device Type
8. Pediatric Interventional Cardiology Market by Procedure
9. Pediatric Interventional Cardiology Market by End User
10. Regional Analysis
11. Company Profiles
12. Use Cases and Best Practices
13. Conclusion
Related Reports
Pediatric Cancer Biomarker Market Report
Pediatric Hospitals Market Forecast
Minimally Invasive Surgery Market Report
Pediatric Clinical Trials Market Outlook
Cardiovascular Devices Market Trends
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
